Abstract
Objective: Robotic hysterectomies are becoming increasingly common in the United States. Although benefits exist, risks are also present. The purpose of this study was to see what percentage of women with migraine headaches had a post-operative exacerbation.Study design: Records were examined for the diagnosis of migraine headaches as well as post-operative diagnosis of a headache. Records were also examined for age, estimated blood loss, total skin to skin operative time and body mass index.Results: Surgeries and records for 100 women were examined. Only 6% of women complained of post-operative headaches. However, 45% of women with history of migraines complained of post-operative headaches (p <0.001). Age was the only significant factor with women having post-operative headaches being significantly younger (p = 0.009).Conclusion: Post-operative headaches were more common in women with a pre-operative history of migraine headaches than in those without a history. Patients with a history of migraines should be warned of this risk.
Highlights
Since its initial development in the early 1970’s, robotic-assisted laparoscopic surgery has become an increasingly popular procedure
Post-operative headaches were more common in women with a pre-operative history of migraine headaches than in those without a history
Patients with a history of migraines should be warned of this risk
Summary
Since its initial development in the early 1970’s, robotic-assisted laparoscopic surgery has become an increasingly popular procedure. The use of robotics in gynecologic surgery has been demonstrated in a wide range of cases, with application for both benign and malignant conditions. One such disease that can be staged and/or treated with robotic hysterectomy is endometrial carcinoma. It was projected that in 2013, there will be approximately 54,870 new cases of cancer of the uterine corpus in the United States alone with > 10,000 deaths (Siegel, Miller, & Jemal, 2015). Most of these cases involve women over 40 years old, with a mean age of 61 years. If caught at an early stage prior to spread beyond the uterus, there is a favorable prognosis without need of adjuvant therapy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.